Vascular endothelial growth factor and chemokine receptor-3 in the pathogenesis of pterygium
Author:
Fund Project:

Xiangyang Municipal Science and Technology Planning Project(No.2015zd11)

  • Article
  • | |
  • Metrics
  • |
  • Reference [22]
  • |
  • Related
  • | | |
  • Comments
    Abstract:

    AIM: To investigate the expression of vascular endothelial growth factor(VEGF)and chemokine receptor 3(CCR3)in pterygium.

    METHODS: The expression of VEGF and CCR3 were detected in 18 patients(18 eyes)with pterygium and compared with the normal conjunctiva epithelium in other 14 cases(14 eyes). The histological differences between the two groups were compared by hematoxylin and eosin(HE)staining. The expression of VEGF and CCR3 in pterygium and normal conjunctival tissues were analyzed by immunofluorescence and immunohistochemical. The mRNA expression of VEGF and CCR3 were assessed by Real-time PCR.

    RESULTS: Compared with normal conjunctival tissue, the epithelial layer of pterygium was obvious thickening, the stromal layer was more disordered, and the expression levels of VEGF(0.69±0.0875 vs 0.05±0.0024)and CCR3(0.45±0.0248 vs 0.03±0.0074)were significantly elevated(all P<0.01). The expression level of VEGF mRNA in pterygium was about 12 times that of normal conjunctival tissue(12.33±2.84 vs 1.00±0.08), and the expression level of CCR3 mRNA was about 160 times as many as conjunctival tissue(159.60±34.15 vs 1.00±0.09).

    CONCLUSION: The expression of VEGF and CCR3 in pterygium was significantly increased, suggesting that they may be involved in the occurrence of pterygium and promote the development of the disease.

    Reference
    1 Chui J,Di Girolamo N,Wakefield D,et al. The pathogenesis of pterygium:current concepts and their therapeutic implications. Ocul Surf 2008; 6(1):24-43
    2 Detorakis ET,Zaravinos A,Spandidos DA. Growth factor expression in ophthalmic pterygia and normal conjunctiva. Int J Mol Med 2010; 25(4):513-516
    3郝尚臣.人翼状胬肉中细胞因子及其受体的改变.眼科新进展 2009; 29(6):425-427
    4郑兰育.复发性翼状胬肉中VEGF表达情况的临床研究.中国医学创新 2016; 13(30):39-42
    5 Bianchi E,Scarinci F,Grande C,et al. Immunohistochemical Profile and VEGF,TGF-β and PGE2 inhuman pterygium and normal conjunctiva:experimental study and review of the literature. Int J Immunopathol Pharmacol 2012; 25(3):607-615
    6 Talghini S,Shenasi A. Concomitant examination of inflammation and angiogenesis in the pathogenesis of primary moderate pterygium in a well-designed case-control study. Pak J Biol Sci 2013; 16(19):1046-1050
    7黄丽娜,姚晓明.翼状胬肉成纤维细胞中COX-2的表达及其抑制剂的实验研究.国际眼科杂志 2006; 6(1):5-8
    8 Cárdenas-Cantú E,Zavala J,Valenzuela J,et al. Molecular Basis of Pterygium Development. Semin Ophthalmol 2014; 31(6):567-583
    9 Poenaru Sava MG,Raica ML,Cimpean AM,et al. VEGF mRNA assessment in human pterygium:a new ‘Scope' for a future hope. Ophthalmic Res 2014; 52(3):130-135
    10 Wang Y,Lin J,Chen L,et al. Expression of Peroxiredoxin 2 and Vascular Endothelial Growth Factor Receptor 2 in Pterygium. Cornea 2017; 36(7):841-844
    11 Zhang J,Zhang M,Li X,et al. Correlation of vascular endothelial growth factor and CD105-microvascular density in primary pterygium. J Huazhong Univ Sci Technolog Med Sci 2011; 31(4):560-564
    12 Gharaee H,Shayegan MR,Khakzad MR,et al. The expression of vascular endothelial growth factor in pterygium tissue of atopic patients. Int Ophthalmol 2014; 34(6):1175-1181
    13 Mak RK,Chan TC,Marcet MM,et al. Use of anti-vascular endothelial growth factor in the management of pterygium. Acta Ophthalmol 2017; 95(1):20-27
    14吴宪巍,刘哲丽.CCR3在湿性年龄相关性黄斑变性中的研究进展.国际眼科杂志 2014; 14(3):457-459
    15 Gumus K,Karakucuk S,Mirza GE,et al. Overexpression of vascular endothelial growth factor receptor 2 in pterygia may have a predictive value for a higher postoperative recurrence rate. Br J Ophthalmol 2014; 98(6):796-800
    16 Hirahara S,Nozaki M,Ohbayashi M,et al. Suppression of Retinal Neovascularization by Anti-CCR3 Treatment in an Oxygen-Induced Retinopathy Model in Mice. Ophthalmic Res 2017; 58(1):56-66
    17赫雪飞.CCR3拮抗剂在实验性角膜新生血管发生过程中的作用和机制.苏州大学 2013
    18 Zhou WJ,Liu GQ,Li LB,et al. Inhibitory effect of CCR3 signal on alkali-induced corneal neovascularization. Int J Ophthalmol 2012; 5(3):251-257
    19 Krizova D,Vokrojova M,Liehneova K,et al. Treatment of Corneal Neovascularization Using Anti-VEGF Bevacizumab. J Ophthalmol 2014; 2014:178132
    20 Nagai N,Ju M,Izuminagai K,et al. Novel CCR3 Antagonists Are Effective Mono- and Combination Inhibitors of Choroidal Neovascular Growth and Vascular Permeability. Am J Pathol 2015; 185(9): 2534-2549
    21 Lee JK,Song YS,Ha HS,et al. Endothelial progenitor cells in pterygium pathogenesis. Eye(Lond) 2007; 21(9):1186-1193
    22 Wang H,Wittchen ES,Jiang Y,et al. Upregulation of CCR3 by age-related stresses promotes choroidal endothelial cell migration via VEGF-dependent and -independent signaling. Invest Ophthalmol Vis Sci 2011; 52(11):8271-8277
    Related
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

Hui Liu, Min Zhang. ,/et al.Vascular endothelial growth factor and chemokine receptor-3 in the pathogenesis of pterygium. Guoji Yanke Zazhi( Int Eye Sci) 2019;19(4):551-554

Copy
Share
Article Metrics
  • Abstract:1056
  • PDF: 1128
  • HTML: 0
  • Cited by: 0
Publication History
  • Received:September 05,2018
  • Revised:February 28,2019
  • Online: March 22,2019